Inventor · disambiguated record
Xuefeng Zhu
Also filed as: ZHU XUEFENG
11 granted patents·9 pending applications·35 citations·filing 2007–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0191US11999730B1AKT1 modulatorsALTEROME THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·2 cites·29 claims
- 0287US8431607B2Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2007·Granted Apr 30, 2013·12 cites·8 claims
- 0384US12018011B2Macrocyclic compounds and compositions, and methods of preparing and using the sameKURA ONCOLOGY INC·Filed 2023·Granted Jun 25, 2024·1 cites·222 claims
- 0483US8592432B2Compounds and compositions as protein kinase inhibitorsCHEN BEI·Filed 2009·Granted Nov 26, 2013·6 cites·9 claims
- 0581US8518931B2Compounds and compositions as kinase inhibitorsJIANG TAO·Filed 2009·Granted Aug 27, 2013·6 cites·19 claims
- 0679US10450273B2N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2017·Granted Oct 22, 2019·3 cites·43 claims
- 0779US2025092040A1Akt1 modulatorsALTEROME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0877US12209087B2AKT1 modulatorsALTEROME THERAPEUTICS INC·Filed 2024·Granted Jan 28, 2025·0 cites·20 claims
- 0977US2025346610A1SUBSTITUTED PYRIDO[4,3-d]PYRIMIDINES AS KRAS MODULATORSALTEROME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1073US12466842B2Substituted pyrido [4,3-d]pyrimidines as KRAS modulatorsALTEROME THERAPEUTICS INC·Filed 2025·Granted Nov 11, 2025·0 cites·30 claims
- 1172US8722692B2Compounds and compositions as Syk kinase inhibitorsCHE JIANWEI·Filed 2010·Granted May 13, 2014·4 cites·23 claims
- 1272US8362050B2Compounds and methods for modulating G protein-coupled receptorsIRM LLC·Filed 2009·Granted Jan 29, 2013·1 cites·11 claims
- 1367US2024287023A1Macrocyclic compounds and compositions, and methods of preparing and using the sameKURA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1464US11066369B2N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2019·Granted Jul 20, 2021·0 cites·24 claims
- 1561US2025152591A1Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitorsKURA ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1648US2013210769A1Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2013·Application pending·0 cites
- 1748US2013096165A1Compounds and methods for modulating g protein-coupled receptorsIRM LLC·Filed 2012·Application pending·0 cites
- 1847US2022127247A1N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of diseaseNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1944US2022071971A1Macrocyclic compounds and their use in the treatment of diseaseNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2034US2011053897A1Compounds and compositions as syk kinase inhibitorsIRM LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xuefeng Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →